IPSC - Century Therapeutics - Stock Forecast

Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

IPSC is currently covered by 7 analysts with an average price target of $9.46. This is a potential upside of $8.2 (650.79%) from yesterday's end of day stock price of $1.26.

Century Therapeutics's activity chart (see below) currently has 13 price targets and 30 ratings on display. The stock rating distribution of IPSC is 95.24% BUY and 4.76% HOLD.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 7.14% with an average time for these price targets to be met of 27.29 days.

Highest price target for IPSC is $12, Lowest price target is $5, average price target is $9.46.

Most recent stock forecast was given by GEULAH LIVSHITS from CHARDAN CAPITAL on 07-Nov-2024. First documented stock forecast 13-Jul-2021.

Currently out of the existing stock ratings of IPSC, 20 are a BUY (95.24%), 1 are a HOLD (4.76%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

$11

$9.78 (801.64%)

14 days ago
(07-Nov-2024)

0/2 (0%)

$9.54 (653.42%)

Buy

$5

$3.78 (309.84%)

$9

15 days ago
(06-Nov-2024)

0/10 (0%)

$3.7 (284.62%)

Buy

$12

$10.78 (883.61%)

$9

5 months 4 days ago
(17-Jun-2024)

0/6 (0%)

$8.85 (280.95%)

Hold

$5

$3.78 (309.84%)

$40

1 years 2 months 24 days ago
(28-Aug-2023)

1/2 (50%)

$2.49 (99.20%)

191

Buy

1 years 6 months 6 days ago
(15-May-2023)

0/1 (0%)

$5.81 (20.61%)

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is IPSC (Century Therapeutics) average time for price targets to be met?

On average it took 27.29 days on average for the stock forecasts to be realized with a an average price target met ratio 7.14

Which analyst has the current highest performing score on IPSC (Century Therapeutics) with a proven track record?

EDWARD TENTHOFF

Which analyst has the current lower performing score on IPSC (Century Therapeutics) with a proven track record?

ERIC JOSEPH

Which analyst has the most public recommendations on IPSC (Century Therapeutics)?

Edward Tenthoff works at PIPER SANDLER and has 7 price targets and 8 ratings on IPSC

Which analyst is the currently most bullish on IPSC (Century Therapeutics)?

Bill Maughan with highest potential upside - $26

Which analyst is the currently most reserved on IPSC (Century Therapeutics)?

Geoff Meacham with lowest potential downside - -$0

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?